CervoMed Inc. (CRVO)
Healthcare
Biotechnology
2.60 $
+0.8%
vs. previous close
Closing price · As of: 3. Aug 2026
CervoMed Inc. (CRVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -23 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.0 | -5.2 | -11 | -12 | -11 | -9.9 | -14 | -15 | -2.6 | -7.4 | -17 | -23 | |
| 0.6 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | – | – | – | |
| 1.6 | 0.6 | – | – | – | 0.6 | 0.7 | 0.9 | 0.3 | 0.4 | 1.4 | 1.4 | |
| – | – | – | – | – | – | – | 0.1 | 2.9 | – | – | – | |
| -2.8 | 0.6 | 1.3 | -2.3 | -0.3 | 1.0 | 1.5 | 0.4 | 0.4 | -0.3 | -0.4 | 2.9 | |
| 0.1 | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.1 | 2.5 | 8.5 | -0.4 | – | – | – | 0.0 | -12 | – | -29 | 18 | |
| – | – | – | – | – | – | – | 6.0 | – | – | – | – | |
| 31 | 2.4 | 1.8 | 20 | 9.9 | 16 | 18 | 33 | 0.0 | 11 | 46 | 4.6 | |
| 22 | -0.3 | -0.4 | 7.3 | -0.9 | 6.2 | 4.3 | 19 | -33 | 3.7 | 1.2 | -0.8 | |
| -9.1 | -5.2 | -11 | -13 | -11 | -9.9 | -14 | -15 | -2.6 | -7.4 | -17 | -23 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.